ST. LOUIS--(BUSINESS WIRE)--Mallinckrodt, the pharmaceuticals business of Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of its morphine sulfate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results